Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Abdurraouf Mokhtar Mahmoud
Observed names:
A. Mokhtar Mahmoud,
Abdurraouf Mahmoud,
Abdurraouf mokhtar saleh Mahmoud
Institutions:
Università degli Studi del Piemonte Orientale “Amedeo Avogadro”,
Azienda Ospedaliero Universitaria Maggiore della Carita
Observed institutions:
Università degli Studi del Piemonte Orientale “Amedeo Avogadro”,
Azienda Ospedaliero Universitaria Maggiore della Carita
ORCID:
0000-0002-3969-0112
Observed ORCID:
0000-0002-3969-0112
OpenAlex ID:
A5088913264
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study
2019
·
Simone Ferrero
, Davide Rossi
, et al.
·
Haematologica
·
159
New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes
2022
·
Marco Gallazzi
, Maghalie Anais Marie Ucciero
, et al.
·
International Journal of Molecular Sciences
·
35
PDF
Integration of [18F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphoma
2025
·
Riccardo Dondolin
, Federico Garrou
, et al.
·
Leukemia
·
34
PDF
Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levels
2025
·
Riccardo Moia
, Donatella Talotta
, et al.
·
Blood Advances
·
29
PDF
Clonally unrelated Richter syndrome are truly de novo diffuse large B‐cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome
2022
·
Chiara Favini
, Donatella Talotta
, et al.
·
British Journal of Haematology
·
26
PDF
Targeting p53 in chronic lymphocytic leukemia
2020
·
Riccardo Moia
, Paola Boggione
, et al.
·
Expert Opinion on Therapeutic Targets
·
26
A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleation
2022
·
Gerard Llimos
, Vincent Gardeux
, et al.
·
Nature Communications
·
23
PDF
Advancements in Nanotechnology for Targeted and Controlled Drug Delivery in Hematologic Malignancies: Shaping the Future of Targeted Therapeutics
2025
·
Abdurraouf Mokhtar Mahmoud
, Clara Deambrogi
·
Applied Biosciences
·
20
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma
2023
·
Annalisa Arcari
, Lugi Rigacci
, et al.
·
Blood Advances
·
20
PDF
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study
2021
·
Abdurraouf Mokhtar Mahmoud
, Federica Biello
, et al.
·
BMC Geriatrics
·
14
PDF
Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformation
2026
·
Chiara Cosentino
, Samir Mouhssine
, et al.
·
HemaSphere
·
12
PDF
Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms
2021
·
Riccardo Moia
, Micol Giulia Cittone
, et al.
·
Frontiers in Oncology
·
12
PDF
Bispecific Monoclonal Antibodies in Diffuse Large B-Cell Lymphoma: Dawn of a New Era in Targeted Therapy
2025
·
Mattia Schipani
, Matteo Bellia
, et al.
·
Cancers
·
10
PDF
Immunological Aspects of Richter Syndrome: From Immune Dysfunction to Immunotherapy
2023
·
Abdurraouf Mokhtar Mahmoud
, Gianluca Gaidano
, et al.
·
Cancers
·
10
PDF
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients
2022
·
Cinzia Borgogna
, Riccardo Bruna
, et al.
·
Blood Cancer Journal
·
10
PDF
XPO1 mutations identify early‐stage CLL characterized by shorter time to first treatment and enhanced BCR signalling
2023
·
Riccardo Moia
, Lodovico Terzi di Bergamo
, et al.
·
British Journal of Haematology
·
9
PDF
Druggable Molecular Pathways in Chronic Lymphocytic Leukemia
2022
·
Mohammad Almasri
, Marah Amer
, et al.
·
Life
·
9
PDF
Genetic Predisposition to Myelodysplastic Syndromes: A Challenge for Adult Hematologists
2021
·
Elena Crisà
, Paola Boggione
, et al.
·
International Journal of Molecular Sciences
·
9
PDF
Precision Medicine in Systemic Mastocytosis
2021
·
Maura Nicolosi
, Andrea Patriarca
, et al.
·
Medicina
·
8
PDF
Induction of robust humoral immunity against SARS‐CoV ‐2 after vaccine administration in previously infected haematological cancer patients
2022
·
Cinzia Borgogna
, Riccardo Bruna
, et al.
·
British Journal of Haematology
·
4
The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana Linfomi MCL0208 clinical trial
2025
·
Riccardo Moia
, Simone Ragaini
, et al.
·
Leukemia
·
3
PDF
New Frontiers in Monoclonal Antibodies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
2023
·
Mattia Schipani
, Giulia Maria Rivolta
, et al.
·
Cancers
·
3
PDF
Impact of the G8 score on the outcome of a cohort of elderly patients with solid or hematological malignancies.
2021
·
Federica Biello
, Alessia Mennitto
, et al.
·
Journal of Clinical Oncology
·
3
Assessing prognosis of chronic lymphocytic leukemia using biomarkers and genetics
2020
·
Riccardo Moia
, Andrea Patriarca
, et al.
·
Expert Opinion on Orphan Drugs
·
3
PDF
Innovative Use of Fostamatinib in Managing Refractory Immune Thrombocytopenia in an HIV ‐Positive Patient: A Case Report
2025
·
Matteo Bellia
, Riccardo Moia
, et al.
·
Clinical Case Reports
·
2
PDF
Show more works
View as search
Works count:
46
Citation count:
504
H-index:
12
I10-index:
15
Year
Topic
Type